Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Offer Talks Terminated

27 Sep 2013 15:12

RNS Number : 1537P
W&G Investments PLC
27 September 2013
 



 

 

W&G INVESTMENTS PLC

 

 Termination of offer talks

On 27 September 2013, the board of directors of W&G Investments PLC (the "Company") was informed by the board of directors of The Royal Bank of Scotland Group plc ("RBSG") that RBSG has conclusively terminated discussions with the Company in respect of the potential acquisition of certain assets and liabilities relating to the Rainbow branches that are currently held by RBSG (the "Potential Acquisition") following the submission to RBSG of an updated proposal. Defined terms in this announcement shall have the same meaning as those set out in the Company's admission document dated 15 August 2013 ("Admission Document").

 

The final and improved proposal that the Company put to RBSG with respect to the Potential Acquisition comprised £1.1 billion in cash up front, £250 million of warrants with a return on equity strike threshold of 12.5% and additional value that may have accrued to RBSG by reference to the performance of the Rainbow business between the Signing Date and the Completion Date. The total consideration, including any additional value that would accrue to RBSG, would have amounted to up to £1.75 billion.

 

As set out in its Admission Document, the Potential Acquisition had already been identified and would constitute a reverse takeover for the purposes of the AIM Rules and, consequently, trading in the Company's Ordinary Shares was suspended on Admission. As the Company is no longer pursuing the Potential Acquisition, trading in its Ordinary Shares on AIM will shortly commence.

 

In the Admission Document the Company stated that if, within 6 months of Admission, for any reason the Company chose not or was not in a position to pursue the Potential Acquisition, the Company intended to return any remaining cash (after payment of all of its expenses) to its Shareholders by the most efficient route, seek cancellation of the Ordinary Shares from AIM and apply for a voluntary members' liquidation. Further announcements in this regard will be made when appropriate.

 

Andrew Higginson, Chairman of the Company, said: "We are disappointed that our final proposal was not accepted by the Board of RBS as we believed it offered full and fair value for the assets on offer and would have provided certain value to RBS shareholders. Nonetheless, I would like to thank all our investors for backing our offer and providing us with the financial support that brought us this far. We now intend to return the remaining cash in W&G Investments to investors with the minimum of delay. We estimate this to be approximately £10m."

Contacts:

 

 

W&G Investments PLC +44 (0) 1992 644 909 

Andrew Higginson (Non-Executive Chairman)

 

Canaccord Genuity Limited +44 (0) 20 7523 8350

 

Charles Williams (Advisory)

Bruce Garrow (Corporate Broking)

Peter Stewart (Corporate Broking)

 

Baden Hill +44 (0) 20 7448 4719

Matthew Wakefield

Maitland (PR advisers) +44 (0) 20 7379 5151

Neil BennettAndy Donald

 

 

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as financial adviser and nominated adviser to the Company and will not be acting for any other person or otherwise be responsible to any person for providing the protections afforded to clients of Canaccord Genuity Limited.

 

Baden Hill, which is a trading name of Fiske plc, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority and is a member of the London Stock Exchange, is acting exclusively for the Company and will not be acting for any other person or otherwise be responsible to any person for providing the protections afforded to clients of Baden Hill.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OTTUBRSROWAKUAR
Date   Source Headline
17th Mar 20205:24 pmRNSDirectorate Change
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20208:30 amRNSMorgan Stanley European Financials Conference
16th Mar 20205:14 pmRNSNatWest Markets N.V. 2019 ARA
10th Mar 20204:51 pmRNSDirector/PDMR Shareholding
2nd Mar 20202:34 pmRNSDirector/PDMR Shareholding
28th Feb 20204:29 pmRNSCorrection of Dividend Declaration
28th Feb 20201:58 pmRNSTotal Voting Rights and Capital
28th Feb 20207:00 amRNSFiling of Annual Report on Form 20-F with US SEC
27th Feb 20209:55 amRNSBlock Listing Cancellation
24th Feb 202012:40 pmRNSDividend Declaration
20th Feb 20204:10 pmRNSHolding(s) in Company
14th Feb 20203:58 pmRNSRBSG ENTM Publication of Suppl.Prospcts
14th Feb 20207:01 amRNSAnnual Financial Report
14th Feb 20207:00 amRNSFinal Results
31st Jan 20202:12 pmRNSTotal Voting Rights and Capital
30th Jan 20203:57 pmRNSDirector/PDMR Shareholding
16th Jan 20202:08 pmRNSForm 8.3 - Accesso Technology Group plc
2nd Jan 20201:58 pmRNSForm 8.3 - Accesso Technology Group plc
31st Dec 20191:10 pmRNSDirector/PDMR Shareholding
31st Dec 201911:20 amRNSTotal Voting Rights and Capital
30th Dec 20193:02 pmRNSForm 8.3 - Accesso Technology Group plc
20th Dec 20197:00 amRNSPublication of Suppl.Prospcts replacement
19th Dec 20195:40 pmRNSPublication of Suppl.Prospcts
19th Dec 20197:00 amRNSNatWest Markets Change in Executive Directors
16th Dec 20195:47 pmRNS2019 Bank of England stress test results
4th Dec 201912:34 pmRNSForm 8.3 - Accesso Technology Group plc
2nd Dec 20195:34 pmRNSPublication of Suppl.Prospcts
29th Nov 20192:20 pmRNSDirector/PDMR Shareholding
29th Nov 20191:28 pmRNSAnnouncement of NatWest Markets N.V. Transfer
29th Nov 201912:01 pmRNSTotal Voting Rights and Capital
27th Nov 201911:56 amRNSDividend Declaration
21st Nov 20196:26 pmRNSPublication of a Prospectus
21st Nov 201910:45 amRNSReduction in Pillar 2A capital requirements
14th Nov 201911:23 amRNSPublication of Final Terms
13th Nov 20193:00 pmRNSForm 8.3 - Accesso Technology Group plc
8th Nov 20193:00 pmRNSDirector/PDMR Shareholding
1st Nov 20194:12 pmRNSDirector/PDMR Shareholding
31st Oct 20193:30 pmRNSDirector/PDMR Shareholding
31st Oct 20192:08 pmRNSTotal Voting Rights and Capital
30th Oct 20199:38 amRNSRBSG pricing of US$750mn of Subordinated Notes
25th Oct 20195:22 pmRNSPublication of Suppl.Prospcts
24th Oct 20197:00 amRNSQ3 Interim Management Statement
16th Oct 20192:54 pmRNSForm 8.3 - Accesso Technology Group plc
8th Oct 201911:35 amRNSBlock Listing Six Monthly Return
3rd Oct 20191:08 pmRNSPublication of Final Terms
1st Oct 20195:29 pmRNSDirector/PDMR Shareholding
30th Sep 20193:28 pmRNSTotal Voting Rights
24th Sep 20198:30 amRNSBank of America Merrill Lynch Annual Conference

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.